HCPCS Level IIdrugActive
J1745
Infliximab not biosimil 10mg
BETOS: O1E
Effective: 2017-01-01
Referenced in 7 policies
Description
Injection, infliximab, excludes biosimilar, 10 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Remicade
Manufacturer
Janssen Biotech, Inc.
HCPCS Dosage
10 MG
Billing Units
10.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.